Cargando…

Modular Orthopaedic Tissue Engineering With Implantable Microcarriers and Canine Adipose-Derived Mesenchymal Stromal Cells

Mesenchymal stromal cells (MSC) hold significant potential for tissue engineering applications. Modular tissue engineering involves the use of cellularized “building blocks” that can be assembled via a bottom-up approach into larger tissue-like constructs. This approach emulates more closely the com...

Descripción completa

Detalles Bibliográficos
Autores principales: Simitzi, Chara, Vlahovic, Maja, Georgiou, Alex, Keskin-Erdogan, Zalike, Miller, Joanna, Day, Richard M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388765/
https://www.ncbi.nlm.nih.gov/pubmed/32775324
http://dx.doi.org/10.3389/fbioe.2020.00816
_version_ 1783564366882275328
author Simitzi, Chara
Vlahovic, Maja
Georgiou, Alex
Keskin-Erdogan, Zalike
Miller, Joanna
Day, Richard M.
author_facet Simitzi, Chara
Vlahovic, Maja
Georgiou, Alex
Keskin-Erdogan, Zalike
Miller, Joanna
Day, Richard M.
author_sort Simitzi, Chara
collection PubMed
description Mesenchymal stromal cells (MSC) hold significant potential for tissue engineering applications. Modular tissue engineering involves the use of cellularized “building blocks” that can be assembled via a bottom-up approach into larger tissue-like constructs. This approach emulates more closely the complexity associated hierarchical tissues compared with conventional top-down tissue engineering strategies. The current study describes the combination of biodegradable porous poly(DL-lactide-co-glycolide) (PLGA) TIPS microcarriers with canine adipose-derived MSC (cAdMSC) for use as implantable conformable building blocks in modular tissue engineering applications. Optimal conditions were identified for the attachment and proliferation of cAdMSC on the surface of the microcarriers. Culture of the cellularized microcarriers for 21 days in transwell insert plates under conditions used to induce either chondrogenic or osteogenic differentiation resulted in self-assembly of solid 3D tissue constructs. The tissue constructs exhibited phenotypic characteristics indicative of successful osteogenic or chondrogenic differentiation, as well as viscoelastic mechanical properties. This strategy paves the way to create in situ tissue engineered constructs via modular tissue engineering for therapeutic applications.
format Online
Article
Text
id pubmed-7388765
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73887652020-08-07 Modular Orthopaedic Tissue Engineering With Implantable Microcarriers and Canine Adipose-Derived Mesenchymal Stromal Cells Simitzi, Chara Vlahovic, Maja Georgiou, Alex Keskin-Erdogan, Zalike Miller, Joanna Day, Richard M. Front Bioeng Biotechnol Bioengineering and Biotechnology Mesenchymal stromal cells (MSC) hold significant potential for tissue engineering applications. Modular tissue engineering involves the use of cellularized “building blocks” that can be assembled via a bottom-up approach into larger tissue-like constructs. This approach emulates more closely the complexity associated hierarchical tissues compared with conventional top-down tissue engineering strategies. The current study describes the combination of biodegradable porous poly(DL-lactide-co-glycolide) (PLGA) TIPS microcarriers with canine adipose-derived MSC (cAdMSC) for use as implantable conformable building blocks in modular tissue engineering applications. Optimal conditions were identified for the attachment and proliferation of cAdMSC on the surface of the microcarriers. Culture of the cellularized microcarriers for 21 days in transwell insert plates under conditions used to induce either chondrogenic or osteogenic differentiation resulted in self-assembly of solid 3D tissue constructs. The tissue constructs exhibited phenotypic characteristics indicative of successful osteogenic or chondrogenic differentiation, as well as viscoelastic mechanical properties. This strategy paves the way to create in situ tissue engineered constructs via modular tissue engineering for therapeutic applications. Frontiers Media S.A. 2020-07-22 /pmc/articles/PMC7388765/ /pubmed/32775324 http://dx.doi.org/10.3389/fbioe.2020.00816 Text en Copyright © 2020 Simitzi, Vlahovic, Georgiou, Keskin-Erdogan, Miller and Day. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Simitzi, Chara
Vlahovic, Maja
Georgiou, Alex
Keskin-Erdogan, Zalike
Miller, Joanna
Day, Richard M.
Modular Orthopaedic Tissue Engineering With Implantable Microcarriers and Canine Adipose-Derived Mesenchymal Stromal Cells
title Modular Orthopaedic Tissue Engineering With Implantable Microcarriers and Canine Adipose-Derived Mesenchymal Stromal Cells
title_full Modular Orthopaedic Tissue Engineering With Implantable Microcarriers and Canine Adipose-Derived Mesenchymal Stromal Cells
title_fullStr Modular Orthopaedic Tissue Engineering With Implantable Microcarriers and Canine Adipose-Derived Mesenchymal Stromal Cells
title_full_unstemmed Modular Orthopaedic Tissue Engineering With Implantable Microcarriers and Canine Adipose-Derived Mesenchymal Stromal Cells
title_short Modular Orthopaedic Tissue Engineering With Implantable Microcarriers and Canine Adipose-Derived Mesenchymal Stromal Cells
title_sort modular orthopaedic tissue engineering with implantable microcarriers and canine adipose-derived mesenchymal stromal cells
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388765/
https://www.ncbi.nlm.nih.gov/pubmed/32775324
http://dx.doi.org/10.3389/fbioe.2020.00816
work_keys_str_mv AT simitzichara modularorthopaedictissueengineeringwithimplantablemicrocarriersandcanineadiposederivedmesenchymalstromalcells
AT vlahovicmaja modularorthopaedictissueengineeringwithimplantablemicrocarriersandcanineadiposederivedmesenchymalstromalcells
AT georgioualex modularorthopaedictissueengineeringwithimplantablemicrocarriersandcanineadiposederivedmesenchymalstromalcells
AT keskinerdoganzalike modularorthopaedictissueengineeringwithimplantablemicrocarriersandcanineadiposederivedmesenchymalstromalcells
AT millerjoanna modularorthopaedictissueengineeringwithimplantablemicrocarriersandcanineadiposederivedmesenchymalstromalcells
AT dayrichardm modularorthopaedictissueengineeringwithimplantablemicrocarriersandcanineadiposederivedmesenchymalstromalcells